Subhash V. Kapre

666 total citations
24 papers, 429 citations indexed

About

Subhash V. Kapre is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Subhash V. Kapre has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 13 papers in Infectious Diseases and 9 papers in Microbiology. Recurrent topics in Subhash V. Kapre's work include Virology and Viral Diseases (10 papers), Vaccine Coverage and Hesitancy (8 papers) and Bacterial Infections and Vaccines (8 papers). Subhash V. Kapre is often cited by papers focused on Virology and Viral Diseases (10 papers), Vaccine Coverage and Hesitancy (8 papers) and Bacterial Infections and Vaccines (8 papers). Subhash V. Kapre collaborates with scholars based in India, United States and Egypt. Subhash V. Kapre's co-authors include Rajeev Dhere, Prasad S. Kulkarni, S. S. Jadhav, Heikki Peltola, Mikko Paunio, Suresh Jadhav, Hitt Sharma, Mrudula Phadke, Sameer Parekh and Gupta Sk and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Virology.

In The Last Decade

Subhash V. Kapre

21 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhash V. Kapre India 13 309 146 123 80 67 24 429
Anne Fiquet France 11 258 0.8× 86 0.6× 62 0.5× 88 1.1× 23 0.3× 22 357
Elena Fragapane Italy 13 437 1.4× 143 1.0× 43 0.3× 40 0.5× 101 1.5× 23 615
Joan Fusco United States 10 247 0.8× 156 1.1× 25 0.2× 131 1.6× 116 1.7× 14 418
Maurice Raux France 7 154 0.5× 88 0.6× 45 0.4× 42 0.5× 66 1.0× 7 371
Reinhard Glueck Switzerland 12 316 1.0× 172 1.2× 31 0.3× 26 0.3× 73 1.1× 19 485
Cathy Maes Belgium 10 326 1.1× 108 0.7× 24 0.2× 42 0.5× 45 0.7× 13 441
Mohinder Sidhu United States 13 583 1.9× 159 1.1× 24 0.2× 139 1.7× 57 0.9× 16 654
Lee-Jah Chang United States 10 277 0.9× 224 1.5× 29 0.2× 58 0.7× 49 0.7× 17 534
Joanne Hiebert Canada 13 364 1.2× 168 1.2× 110 0.9× 10 0.1× 30 0.4× 39 468
Taff Jones Canada 11 260 0.8× 155 1.1× 18 0.1× 35 0.4× 60 0.9× 20 396

Countries citing papers authored by Subhash V. Kapre

Since Specialization
Citations

This map shows the geographic impact of Subhash V. Kapre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhash V. Kapre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhash V. Kapre more than expected).

Fields of papers citing papers by Subhash V. Kapre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhash V. Kapre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhash V. Kapre. The network helps show where Subhash V. Kapre may publish in the future.

Co-authorship network of co-authors of Subhash V. Kapre

This figure shows the co-authorship network connecting the top 25 collaborators of Subhash V. Kapre. A scholar is included among the top collaborators of Subhash V. Kapre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhash V. Kapre. Subhash V. Kapre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Frasch, Carl E., et al.. (2015). Technical Development of a New Meningococcal Conjugate Vaccine. Clinical Infectious Diseases. 61(suppl_5). S404–S409. 13 indexed citations
3.
Mallajosyula, Vamsee, et al.. (2013). Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the ‘Sa’ Antigenic Site. PLoS ONE. 8(1). e55516–e55516. 15 indexed citations
4.
Sharma, Hitt, Sangeeta Yadav, Sanjay Lalwani, et al.. (2012). Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine. Vaccine. 31(3). 444–447. 11 indexed citations
5.
6.
Gogtay, Nithya, Urmila Thatte, Nilima Kshirsagar, et al.. (2012). Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults. Vaccine. 30(50). 7315–7320. 33 indexed citations
7.
Sharma, Hitt, Sanjay Lalwani, Vijay Gupta, et al.. (2011). A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants. Vaccine. 29(13). 2359–2364. 15 indexed citations
8.
9.
Sharma, Hitt, V S Padbidri, Subhash V. Kapre, et al.. (2011). Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. The Journal of Infection in Developing Countries. 5(12). 874–881. 26 indexed citations
10.
11.
12.
Sharma, Hitt, et al.. (2010). No demonstrable association between the Leningrad–Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt. Clinical Microbiology and Infection. 16(4). 347–352. 8 indexed citations
13.
14.
15.
Kulkarni, Prasad S., et al.. (2007). Immunogenicity of Two Modern Tissue Culture Rabies Vaccines in Pre-Exposure Prophylaxis. Human Vaccines. 3(5). 183–186. 3 indexed citations
16.
Peltola, Heikki, Prasad S. Kulkarni, Subhash V. Kapre, et al.. (2007). Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines. Clinical Infectious Diseases. 45(4). 459–466. 107 indexed citations
17.
Kulkarni‐Kale, Urmila, et al.. (2006). Mapping antigenic diversity and strain specificity of mumps virus: A bioinformatics approach. Virology. 359(2). 436–446. 27 indexed citations
18.
Kulkarni, P. R., et al.. (2006). Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults. Vaccine. 24(17). 3457–3460. 19 indexed citations
19.
Kulkarni, Prasad S., Mrudula Phadke, S. S. Jadhav, & Subhash V. Kapre. (2005). No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study. Vaccine. 23(46-47). 5286–5288. 12 indexed citations
20.
Rath, Archana, et al.. (2005). DNA vaccine for rabies: Relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Virus Research. 113(2). 143–152. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Fiquet Breakdown of academic impact, for papers by Elena Fragapane Breakdown of academic impact, for papers by Joan Fusco Breakdown of academic impact, for papers by Maurice Raux Breakdown of academic impact, for papers by Reinhard Glueck Breakdown of academic impact, for papers by Cathy Maes Breakdown of academic impact, for papers by Mohinder Sidhu Breakdown of academic impact, for papers by Lee-Jah Chang Breakdown of academic impact, for papers by Joanne Hiebert Breakdown of academic impact, for papers by Taff Jones
Rankless by CCL
2026